Hanson & Doremus Investment Management’s Alseres Pharmaceutical Inc ALSE Stock Holding History

Hanson & Doremus Investment Management’s Portfolio ALSE Stock Details ALSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-100	Closed	–	–	414
2013 Q2	$0	Buy	+100	New	–	﹤0.01%	366

Hanson & Doremus Investment Management's ALSE Position: Q3 2013 in Review

Hanson & Doremus Investment Management sold out of Alseres Pharmaceutical Inc (ALSE) in Q3 2013, closing a stake of 100 shares.

Hanson & Doremus Investment Management first reported a position in ALSE in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 0 funds tracked by Wall St. Rank hold ALSE as of Q3 2013.

Hanson & Doremus Investment Management reported no remaining Alseres Pharmaceutical Inc position as of Q3 2013 after selling out during the quarter.
Hanson & Doremus Investment Management sold 100 Alseres Pharmaceutical Inc shares in Q3 2013.
Hanson & Doremus Investment Management first reported a position in Alseres Pharmaceutical Inc in Q2 2013 and held it in 1 quarter.
Hanson & Doremus Investment Management's Alseres Pharmaceutical Inc position peaked at $0 in Q2 2013.
0 funds tracked by Wall St. Rank held Alseres Pharmaceutical Inc as of Q3 2013.

Based on Hanson & Doremus Investment Management's 13F filing for Q3 2013, filed 17 Oct 2013.